KIDS
Orthopediatrics Corp
22.60$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.3% | 51.6% | 46.6% | 45.0% | 50.7% | 50.1% | 49.3% | 51.2% | 49.8% | 50.4% | 49.0% | 49.4% | |
| 2.5% | 7.1% | 4.9% | 6.7% | 10.4% | 9.3% | 7.1% | 8.8% | 3.4% | 3.8% | 2.8% | 3.3% | |
| 19.1% | 18.3% | 10.9% | 6.7% | 15.5% | 14.5% | 12.5% | 13.9% | 11.7% | 12.0% | 10.1% | 9.0% | |
| 8.7% | 7.9% | 8.3% | 9.8% | 8.8% | 9.0% | 9.4% | 10.7% | 10.4% | 10.6% | 10.8% | 11.9% | |
| 23.2% | 24.1% | 25.8% | 27.0% | 24.7% | 24.7% | 25.5% | 24.9% | 26.1% | 26.3% | 26.7% | 26.9% | |
| 18.7% | 19.1% | 20.9% | 21.0% | 18.7% | 19.8% | 19.9% | 19.7% | 21.0% | 21.5% | 22.9% | 23.2% | |
| 19.5% | 19.3% | 20.4% | 20.1% | 17.3% | 17.2% | 16.8% | 15.9% | 16.0% | 15.3% | 15.3% | 15.0% | |
| 13.4% | 14.1% | 15.2% | 13.8% | 24.2% | 25.1% | 26.2% | 29.4% | 29.2% | 31.9% | 32.6% | 32.8% | |
| 11.1% | 9.5% | 10.5% | 9.2% | 7.1% | 7.2% | 8.0% | 7.7% | 6.7% | 9.1% | 9.4% | 10.3% | |
| 0.0% | 0.0% | 0.1% | 0.3% | 0.4% | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.6% | 0.0% | |
| 5.2% | 2.9% | 4.5% | 3.9% | 2.4% | 1.9% | 3.0% | 2.5% | 1.5% | 3.7% | 3.9% | 4.3% | |
| 0.2% | 2.3% | 2.3% | 2.3% | 14.8% | 15.4% | 15.5% | 19.3% | 20.1% | 19.6% | 20.0% | 19.4% | |
| 86.6% | 85.9% | 84.8% | 86.2% | 75.8% | 74.9% | 73.8% | 70.6% | 70.8% | 68.1% | 67.4% | 67.2% | |
| -44.2% | -45.1% | -47.0% | -49.1% | -44.9% | -49.8% | -52.4% | -50.3% | -53.7% | -54.1% | -56.9% | -57.3% | |
| 5.3% | 5.2% | 5.2% | 5.4% | 4.7% | 4.9% | 4.9% | 4.6% | 4.7% | 4.6% | 4.7% | 4.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.